259 related articles for article (PubMed ID: 18336655)
1. Transforming growth factor-beta and hepatocyte transdifferentiation in liver fibrogenesis.
Meindl-Beinker NM; Dooley S
J Gastroenterol Hepatol; 2008 Mar; 23 Suppl 1():S122-7. PubMed ID: 18336655
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage.
Dooley S; Hamzavi J; Ciuclan L; Godoy P; Ilkavets I; Ehnert S; Ueberham E; Gebhardt R; Kanzler S; Geier A; Breitkopf K; Weng H; Mertens PR
Gastroenterology; 2008 Aug; 135(2):642-59. PubMed ID: 18602923
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta/Smad signaling in the injured liver.
Breitkopf K; Godoy P; Ciuclan L; Singer MV; Dooley S
Z Gastroenterol; 2006 Jan; 44(1):57-66. PubMed ID: 16397841
[TBL] [Abstract][Full Text] [Related]
4. Sorafenib inhibits transforming growth factor β1-mediated epithelial-mesenchymal transition and apoptosis in mouse hepatocytes.
Chen YL; Lv J; Ye XL; Sun MY; Xu Q; Liu CH; Min LH; Li HP; Liu P; Ding X
Hepatology; 2011 May; 53(5):1708-18. PubMed ID: 21360571
[TBL] [Abstract][Full Text] [Related]
5. Autocrine production of TGF-beta confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes: Role of EGF receptor ligands.
Del Castillo G; Murillo MM; Alvarez-Barrientos A; Bertran E; Fernández M; Sánchez A; Fabregat I
Exp Cell Res; 2006 Sep; 312(15):2860-71. PubMed ID: 16828470
[TBL] [Abstract][Full Text] [Related]
6. Autocrine release of TGF-beta by portal fibroblasts regulates cell growth.
Wells RG; Kruglov E; Dranoff JA
FEBS Lett; 2004 Feb; 559(1-3):107-10. PubMed ID: 14960316
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of a putative liver progenitor population after treatment of fetal rat hepatocytes with TGF-beta.
del Castillo G; Alvarez-Barrientos A; Carmona-Cuenca I; Fernández M; Sánchez A; Fabregat I
J Cell Physiol; 2008 Jun; 215(3):846-55. PubMed ID: 18286537
[TBL] [Abstract][Full Text] [Related]
8. Regulation of transforming growth factor-beta 1-induced apoptosis and epithelial-to-mesenchymal transition by protein kinase A and signal transducers and activators of transcription 3.
Yang Y; Pan X; Lei W; Wang J; Shi J; Li F; Song J
Cancer Res; 2006 Sep; 66(17):8617-24. PubMed ID: 16951175
[TBL] [Abstract][Full Text] [Related]
9. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases.
Gressner OA; Gressner AM
Liver Int; 2008 Sep; 28(8):1065-79. PubMed ID: 18783549
[TBL] [Abstract][Full Text] [Related]
10. TGF beta1 and PDGF AA override collagen type I inhibition of proliferation in human liver connective tissue cells.
Geremias AT; Carvalho MA; Borojevic R; Monteiro AN
BMC Gastroenterol; 2004 Dec; 4():30. PubMed ID: 15579200
[TBL] [Abstract][Full Text] [Related]
11. Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis.
Gressner AM
Kidney Int Suppl; 1996 May; 54():S39-45. PubMed ID: 8731193
[TBL] [Abstract][Full Text] [Related]
12. Expression of extracellular matrix genes in cultured hepatic oval cells: an origin of hepatic stellate cells through transforming growth factor beta?
Wang P; Liu T; Cong M; Wu X; Bai Y; Yin C; An W; Wang B; Jia J; You H
Liver Int; 2009 Apr; 29(4):575-84. PubMed ID: 19323784
[TBL] [Abstract][Full Text] [Related]
13. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?
Gressner OA; Rizk MS; Kovalenko E; Weiskirchen R; Gressner AM
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1024-35. PubMed ID: 18505415
[TBL] [Abstract][Full Text] [Related]
14. Cellular communications and cell-matrix interactions in the pathogenesis of fibroproliferative diseases: liver fibrosis as a paradigm.
Gressner AM; Bachem MG
Ann Biol Clin (Paris); 1994; 52(3):205-26. PubMed ID: 7998677
[TBL] [Abstract][Full Text] [Related]
15. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
16. Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules.
Gressner AM
Z Gastroenterol; 1992 Mar; 30 Suppl 1():5-16. PubMed ID: 1449018
[TBL] [Abstract][Full Text] [Related]
17. [Epithelial-mesenchymal transition of biliary epithelial cells in advanced liver fibrosis].
Schulze F; Schardt K; Wedemeyer I; Konze E; Wendland K; Dirsch O; Töx U; Dienes HP; Odenthal M
Verh Dtsch Ges Pathol; 2007; 91():250-6. PubMed ID: 18314622
[TBL] [Abstract][Full Text] [Related]
18. Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-beta-mediated profibrotic gene expression pattern.
Ruehl M; Erben U; Kim K; Freise C; Dagdelen T; Eisele S; Trowitzsch-Kienast W; Zeitz M; Jia J; Stickel F; Somasundaram R
J Nutr Biochem; 2009 Aug; 20(8):597-606. PubMed ID: 18824344
[TBL] [Abstract][Full Text] [Related]
19. 15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits fibrogenic response in human hepatoma cells.
Suk FM; Chen CH; Lin SY; Cheng CJ; Yen SJ; Hung LF; Liu DZ; Liang YC
Toxicol Lett; 2009 May; 187(1):22-7. PubMed ID: 19429239
[TBL] [Abstract][Full Text] [Related]
20. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition.
Svegliati-Baroni G; De Minicis S; Marzioni M
Liver Int; 2008 Sep; 28(8):1052-64. PubMed ID: 18783548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
